Panel: AI For Drug Discovery

The estimated $2.6 billion price tag of discovering a new drug is driving pharmaceutical and biotechnology companies to use AI to augment their research & development capabilities. Using AI for the identification and validation of drug targets and the designing of new drugs represents a possible healthcare revolution. This panel of drug discovery leaders will explore how AI is impacting drug discovery today and what we can expect over the short-term.